| Dasatinib | Approved Investigational | BUB1B | 701 |
downregulated | Dasatinib results in decreased expression of BUB1B mRNA | 15q15.1 | |
| Dasatinib | Approved Investigational | C1R | 715 |
upregulated | Dasatinib results in increased expression of C1R mRNA | 12p13.31 | |
| Dasatinib | Approved Investigational | C1S | 716 |
upregulated | Dasatinib results in increased expression of C1S mRNA | 12p13.31 | |
| Dasatinib | Approved Investigational | CACNA1C | 775 |
upregulated | Dasatinib results in increased expression of CACNA1C mRNA | 12p13.33 | |
| Dasatinib | Approved Investigational | CALCOCO1 | 57658 |
upregulated | Dasatinib results in increased expression of CALCOCO1 mRNA | 12q13.13 | |
| Dasatinib | Approved Investigational | CARMN | 728264 |
upregulated | Dasatinib results in increased expression of CARMN mRNA | 5q32 | |
| Dasatinib | Approved Investigational | CD274 | 29126 |
downregulated | Dasatinib results in decreased expression of CD274 mRNA | 9p24.1 | |
| Dasatinib | Approved Investigational | CD302 | 9936 |
upregulated | Dasatinib results in increased expression of CD302 mRNA | 2q24.2 | |
| Dasatinib | Approved Investigational | CDC20 | 991 |
downregulated | Dasatinib results in decreased expression of CDC20 mRNA | 1p34.2 | |
| Dasatinib | Approved Investigational | CDC25A | 993 |
downregulated | Dasatinib results in decreased expression of CDC25A mRNA | 3p21.31 | |
| Dasatinib | Approved Investigational | CDC25C | 995 |
downregulated | Dasatinib results in decreased expression of CDC25C mRNA | 5q31.2 | |
| Dasatinib | Approved Investigational | CDC6 | 990 |
downregulated | Dasatinib results in decreased expression of CDC6 mRNA | 17q21.2 | |
| Dasatinib | Approved Investigational | CDC7 | 8317 |
downregulated | Dasatinib results in decreased expression of CDC7 mRNA | 1p22.1 | |
| Dasatinib | Approved Investigational | CDCA2 | 157313 |
downregulated | Dasatinib results in decreased expression of CDCA2 mRNA | 8p21.2 | |
| Dasatinib | Approved Investigational | CDCA3 | 83461 |
downregulated | Dasatinib results in decreased expression of CDCA3 mRNA | 12p13.31 | |
| Dasatinib | Approved Investigational | CDCA5 | 113130 |
downregulated | Dasatinib results in decreased expression of CDCA5 mRNA | 11q13.1 | |
| Dasatinib | Approved Investigational | CDCA8 | 55143 |
downregulated | Dasatinib results in decreased expression of CDCA8 mRNA | 1p34.3 | |
| Dasatinib | Approved Investigational | CDK1 | 983 |
downregulated | Dasatinib results in decreased expression of CDK1 mRNA | 10q21.2 | |
| Dasatinib | Approved Investigational | CDK2 | 1017 |
downregulated | Dasatinib results in decreased expression of CDK2 mRNA | 12q13.2 | |
| Dasatinib | Approved Investigational | CDKN3 | 1033 |
downregulated | Dasatinib results in decreased expression of CDKN3 mRNA | 14q22.2 | |
| Dasatinib | Approved Investigational | CENPA | 1058 |
downregulated | Dasatinib results in decreased expression of CENPA mRNA | 2p23.3 | |
| Dasatinib | Approved Investigational | CENPE | 1062 |
downregulated | Dasatinib results in decreased expression of CENPE mRNA | 4q24 | |
| Dasatinib | Approved Investigational | CENPF | 1063 |
downregulated | Dasatinib results in decreased expression of CENPF mRNA | 1q41 | |
| Dasatinib | Approved Investigational | CENPH | 64946 |
downregulated | Dasatinib results in decreased expression of CENPH mRNA | 5q13.2 | |
| Dasatinib | Approved Investigational | CENPI | 2491 |
downregulated | Dasatinib results in decreased expression of CENPI mRNA | Xq22.1 | |